Skip to main content

Advertisement

Figure 4 | Malaria Journal

Figure 4

From: Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development

Figure 4

Distribution of proportion cured within the EC50 and k 1 deciles derived from the 5000 parameter sets for the anti-malarial combination therapy, dihydroartemisinin (DHA) and piperaquine (PQ). Top panels are for dihydroartemisinin (EC50 – left hand side, kmax right hand side) and bottom panels are for piperaquine (EC50 – left hand side, kmax right hand side).

Back to article page